Integrity in Medical Research
A review of the background of misconduct in medical research and the evidence for misconduct in clinical trials and other research. It is clear that not all wrong-doing is discovered, and the prevalence of different forms of misconduct is unknown. When presented with evidence, the reaction of scientific and other authorities is not always constructive: science as a system does not deal well with misconduct. Opportunities to bring greater integrity within our own spheres will be discussed.
Speaker: Professor Stephen Evans, Professor of Pharmacoepidemiology, London School of Hygiene and Tropical Medicine
Part of the Science, Health and the Health of our Society, PRIME 10th Anniversary Symposium, 31st March 2012.
To find out more about this event or book a place visit our website.
Further speaker details:
Stephen initially trained in Physics and Computing, and it was the latter that brought him to The Royal London Hospital in 1970. There, he developed an interest in statistics, and moved into medical education and research. He was appointed Professor of Medical Statistics in 1990.
1995-99 and 2000-02: UK Medicines Control Agency (now the MHRA), dealing with major drug safety issues such as HRT and breast cancer; vitamin K and childhood cancer; MMR and autism.
1999-2001: He served as a statistical advisor to the Bristol Royal Infirmary Inquiry.
2002 to present: Professor of Pharmacoepidemiology at the London School of Hygiene and Tropical Medicine (LSHTM) since 2002. He was President of the International Society of Pharmacoepidemiology for 2010/11.
Stephen serves as an independent co-opted member of the European Medicines Agency’s committee that deals with drug safety, and a member of the WHO Global Advisory Committee on Vaccine Safety.
He is an Associate Editor of Pharmacoepidemiology and Drug Safety, and on various editorial boards, including the British Journal of Clinical Pharmacology. He has been a statistical advisor to the British Medical Journal and was a member of its editorial review committee for over 15 years. He has contributed chapters to all four editions of the BMJ book “Fraud and Misconduct in Medical Research”.
Speaker: Professor Stephen Evans, Professor of Pharmacoepidemiology, London School of Hygiene and Tropical Medicine
Part of the Science, Health and the Health of our Society, PRIME 10th Anniversary Symposium, 31st March 2012.
To find out more about this event or book a place visit our website.
Further speaker details:
Stephen initially trained in Physics and Computing, and it was the latter that brought him to The Royal London Hospital in 1970. There, he developed an interest in statistics, and moved into medical education and research. He was appointed Professor of Medical Statistics in 1990.
1995-99 and 2000-02: UK Medicines Control Agency (now the MHRA), dealing with major drug safety issues such as HRT and breast cancer; vitamin K and childhood cancer; MMR and autism.
1999-2001: He served as a statistical advisor to the Bristol Royal Infirmary Inquiry.
2002 to present: Professor of Pharmacoepidemiology at the London School of Hygiene and Tropical Medicine (LSHTM) since 2002. He was President of the International Society of Pharmacoepidemiology for 2010/11.
Stephen serves as an independent co-opted member of the European Medicines Agency’s committee that deals with drug safety, and a member of the WHO Global Advisory Committee on Vaccine Safety.
He is an Associate Editor of Pharmacoepidemiology and Drug Safety, and on various editorial boards, including the British Journal of Clinical Pharmacology. He has been a statistical advisor to the British Medical Journal and was a member of its editorial review committee for over 15 years. He has contributed chapters to all four editions of the BMJ book “Fraud and Misconduct in Medical Research”.
